ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

Veure altres versions (1)

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Descripció completa

Dades bibliogràfiques
Autor principal:	R.T. Saygitov
Format:	Article
Idioma:	English
Publicat:	"Paediatrician" Publishers LLC 2008-08-01
Col·lecció:	Вопросы современной педиатрии
Accés en línia:	https://vsp.spr-journal.ru/jour/article/view/1441

Ítems similars

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
per: R.T. Saygitov
Publicat: (2008-01-01)

Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
per: Cardile S, et al.
Publicat: (2012-02-01)

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
per: Yu. V. Yevsyutina
Publicat: (2018-08-01)

Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
per: Gold Benjamin D, et al.
Publicat: (2009-11-01)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
per: Roy C Orlando, et al.
Publicat: (2010-09-01)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
per: Tang RS, et al.
Publicat: (2013-10-01)

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
per: Nima Arezoomandi, et al.
Publicat: (2019-02-01)

The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
per: El-Dika Samer, et al.
Publicat: (2005-01-01)

Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy
per: Adel Salah Bediwy, et al.
Publicat: (2011-01-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
per: R.T. Saygitov
Publicat: (2010-11-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
per: R.T. Saygitov
Publicat: (2010-01-01)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
per: Su Jin Hong, et al.
Publicat: (2016-11-01)

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
per: Hyun Lim, et al.
Publicat: (2025-01-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
per: R.T. Saygitov
Publicat: (2008-04-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
per: R.T. Saygitov
Publicat: (2009-09-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
per: R.T. Saygitov
Publicat: (2008-01-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
per: R.T. Saygitov
Publicat: (2009-01-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
per: R.T. Saygitov
Publicat: (2008-06-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
per: R.T. Saygitov
Publicat: (2008-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
per: E.I. Alexeeva, et al.
Publicat: (2007-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
per: E.I. Alexeeva, et al.
Publicat: (2007-01-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
per: R.T. Saygitov
Publicat: (2008-12-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
per: R.T. Saygitov
Publicat: (2008-01-01)

Esomeprazole-induced lichen planus
per: Miguel Santos-Coelho, et al.
Publicat: (2023-04-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
per: R.T. Saygitov
Publicat: (2008-01-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
per: R.T. Saygitov
Publicat: (2008-01-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
per: R.T. Saygitov
Publicat: (2008-10-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
per: R.T. Saygitov
Publicat: (2008-01-01)

EVALUATION OF PSORIASIS TREATMENT WITH ESOMEPRAZOLE - A PILOT STUDY
per: Mauro BAFUTTO, et al.

Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
per: V. M. Kosman, et al.
Publicat: (2023-06-01)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
per: David N Roberts, et al.
Publicat: (2011-03-01)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
per: Chiang HH, et al.
Publicat: (2019-04-01)

Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
per: Furuta T, et al.
Publicat: (2012-05-01)

Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study
per: Jae Kyun Choi, et al.
Publicat: (2020-06-01)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
per: Jenna Skieneh, et al.
Publicat: (2016-04-01)

Esomeprazole: a Safe Alternative to Lansoprazole Allergy?
per: Muammer Kara, et al.
Publicat: (2014-08-01)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
per: Ali Jaber, et al.
Publicat: (2022-10-01)

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
per: Simone Marconcini, et al.
Publicat: (2019-10-01)

Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study
per: Youssef Nader N, et al.
Publicat: (2010-06-01)

EFFECTIVENESS OF EDITING IN PREPARATION OF ORIGINAL ARTICLES: RESULTS OF RANDOMIZED CONTROLLED STUDY
per: R.T. Saygitov
Publicat: (2010-11-01)